Health
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Key Points
Researchers are studying why patients, like former Senator Ben Sasse, eventually develop resistance to the drug daraxonrasib.
Researchers are studying why patients, like former Senator Ben Sasse, eventually develop resistance to the drug daraxonrasib.